The Netherlands
The Dutch medicines evaluation board, College ter Beoordeling van Geneesmiddelen (CBG), has a planning tool with timeslots available for various assessment procedures. The use of this planning tool has been mandatory for the application of decentralized procedures (DCP) with the Netherlands as the reference country (RMS), but from July 1, 2025, this obligation also applies to the following application procedures:
- Line extension within a DCP (NL as RMS)
- Mutual recognition procedure with the Netherlands as reference country: MRP
- MRP Repeat-Use with the Netherlands as reference country: RUP
- (Re-)consultation procedure for a medical device
- National registration application (except for duplex)
- National scientific advice
- Parallel application
Requesting a timeslot must be done prior to the application process. Applicants must complete an administrative data form and attach it to the timeslot request.
source: CBG-MEB